News | April 29, 2015

IBA, Pravida to Collaborate on Single-Room Proton Therapy in Europe

Agreement will integrate IBA’s compact Proteus One system with Pravida’s turnkey radiation protection facilities

IBA, Pravida Bau, single-room proton therapy, Europe

April 29, 2015 — Ion Beam Applications S.A. (IBA) and Pravida Bau GmBH announced an agreement to supply integrated single-room proton therapy solutions to customers in Europe.

The solution will combine Proteus One, IBA’s compact proton therapy system, with the patented Forster – Sandwich – Construction method exclusively installed by Pravida Bau, which designs and builds turnkey radiation protection facilities. This construction method is fast and easy to install and reduces the environmental footprint of the project through the use of local material filling, rather than overreliance on concrete.

Of the 34 proton therapy centers ordered to IBA, seven have chosen for Proteus One, IBA’s compact single-room proton therapy solution that can be integrated easily into many kinds of healthcare settings. The combination of smaller system size, strong clinical capabilities and patient-centered design of ProteusONE makes proton therapy more accessible to clinical institutions and their patients worldwide.

The system delivers intensity modulated proton therapy (IMPT), which combines the precise dose delivery of pencil beam scanning (PBS) with the dimensionally accurate imaging of 3-D cone beam computed tomography (CBCT), enabling physicians to truly track where protons will be targeting tumor cells.

For more information:

Related Content

Cleveland Clinic Researchers Reveal Biomarker for Guiding Prostate Cancer Treatment
News | Prostate Cancer | October 17, 2017
October 17, 2017 — Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-r
IBA Announces First Use of Gating With Active Scanning Proton Therapy in Italy
News | Proton Therapy | October 17, 2017
October 17, 2017 — The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA announced the successful comp
Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation Therapy, MRI guided RT.
Sponsored Content | Webinar | Radiation Therapy | October 13, 2017
The webinar "Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation" will be presented by Par
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent...
News | Image Guided Radiation Therapy (IGRT) | October 10, 2017
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company...
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
David Beyer, M.D., chairman of the board for the American Society of Radiation Oncology (ASTRO), discusses the key th
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
Benjamin Movsas, M.D., chair of the American Society for Radiation Oncology (ASTRO) Scientific Committee, explains ho
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
Overlay Init